Resilience, Cardiological Outcome, and Their Correlations With Anxious-Depressive Symptoms and Quality of Life in

Celeste Isella1, Alessandra Gasparini1, Giulia Lucca1

  • 1Department of Medicine and Surgery, Section of Psychiatry, University of Insubria, Varese, Italy.

Frontiers in Psychiatry
|December 13, 2021
PubMed

Insights

Higher resilience correlates with better quality of life and fewer anxiety-depressive symptoms in patients with implantable cardioverter defibrillators (ICD). Cardiac events negatively impact quality of life, while resilience remains stable.

Area of Science:

  • Cardiology
  • Psychiatry
  • Psychology

Background:

  • Resilience acts as a protective factor against psychiatric disorders and is increasingly recognized in cardiovascular pathology.
  • This study investigates the link between resilience, mental health, and quality of life in patients with implantable cardioverter defibrillators (ICDs).

Purpose of the Study:

  • To explore the correlation between individual resilience, depressive and anxiety symptoms, and quality of life in ICD patients.
  • To compare these variables between patients who experienced major cardiac events and those who did not during follow-up.

Main Methods:

  • A longitudinal study involving 80 cardiology patients evaluated at three time points (T0, T1, T2).
  • Utilized the 14-item Resilience Scale (RS-14), Hospital Anxiety and Depression Scale (HADS), and WHO Quality of Life-Brief Version (WHOQOL-Bref).

Main Results:

  • Significant positive correlation found between resilience and all quality of life domains.
  • Negative correlations observed between resilience and anxiety/depressive symptoms, and between these symptoms and quality of life.
  • Patients with cardiac events showed decreased quality of life and increased anxiety/depression, with stable resilience; those without events exhibited increasing resilience.

Conclusions:

  • Resilience is significantly associated with mental well-being and quality of life in ICD patients.
  • The RS-14 scale is a potentially valuable tool for assessing resilience in cardiology due to its ease of use.
  • Further research is warranted to confirm the clinical utility of resilience assessment in cardiovascular care.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
60
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
61
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
86
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
106
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
47
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
83